224 related articles for article (PubMed ID: 31026210)
1. Immune Checkpoint Blockade in PD-L1-Positive Platinum-Refractory Cervical Carcinoma.
Tewari KS
J Clin Oncol; 2019 Jun; 37(17):1449-1454. PubMed ID: 31026210
[No Abstract] [Full Text] [Related]
2. Which Patients With Cervical Squamous Cell Carcinoma Might Benefit From Neoadjuvant Chemotherapy?
Mahmoud O; Einstein MH
J Clin Oncol; 2018 Jun; 36(16):1543-1547. PubMed ID: 29668367
[TBL] [Abstract][Full Text] [Related]
3. A case report of carcinoma of uterine cervix throwing heterochronous metastasis to the skin, spleen, and pancreas: the role of multimodality treatment approach.
Gupta PK; Lal P; Tiwari A
J Egypt Natl Canc Inst; 2019 Dec; 31(1):8. PubMed ID: 32372163
[TBL] [Abstract][Full Text] [Related]
4. Management of refractory metastatic anal squamous cell carcinoma following disease progression on traditional chemoradiation therapy.
Silva NN; Eng C
J Adv Pract Oncol; 2012 May; 3(3):161-9. PubMed ID: 25031942
[TBL] [Abstract][Full Text] [Related]
5. The Treatment of Pelvic Locoregional Recurrence of Cervical Cancer After Radical Surgery With Intensity-Modulated Radiation Therapy Compared With Conventional Radiotherapy: A Retrospective Study.
Yin YJ; Li HQ; Sheng XG; Du XL; Wang C; Lu CH; Pan CX
Int J Gynecol Cancer; 2015 Jul; 25(6):1058-65. PubMed ID: 25647254
[TBL] [Abstract][Full Text] [Related]
6. Maximizing the Clinical Benefit of Anthracyclines in Addition to Taxanes in the Adjuvant Treatment of Early Breast Cancer.
Curigliano G; Criscitiello C
J Clin Oncol; 2017 Aug; 35(23):2600-2603. PubMed ID: 28661760
[TBL] [Abstract][Full Text] [Related]
7. Timing Is Everything: What Is the Optimal Duration After Chemoradiation for Surgery for Rectal Cancer?
Goodman KA
J Clin Oncol; 2016 Nov; 34(31):3724-3728. PubMed ID: 27601550
[TBL] [Abstract][Full Text] [Related]
8. A Randomized Controlled Trial Comparing Clinical Outcomes and Toxicity of Lobaplatin- Versus Cisplatin-Based Concurrent Chemotherapy Plus Radiotherapy and High-Dose-Rate Brachytherapy for FIGO Stage II and III Cervical Cancer.
Wang JQ; Wang T; Shi F; Yang YY; Su J; Chai YL; Liu Z
Asian Pac J Cancer Prev; 2015; 16(14):5957-61. PubMed ID: 26320479
[TBL] [Abstract][Full Text] [Related]
9. Concurrent Chemotherapy and Radiation Therapy for Inoperable Locally Advanced Non-Small-Cell Lung Cancer.
Rosenzweig KE; Gomez JE
J Clin Oncol; 2017 Jan; 35(1):6-10. PubMed ID: 27870565
[TBL] [Abstract][Full Text] [Related]
10. Combined pretreatment with
Ji S; Hu Q; Zhu J; Chen J; Chen Q; Liu Z; Shen C; Yang R; Sun H; Wu J; Gu K
Trials; 2018 Aug; 19(1):416. PubMed ID: 30075736
[TBL] [Abstract][Full Text] [Related]
11. Role of Surgical Versus Clinical Staging in Chemoradiated FIGO Stage IIB-IVA Cervical Cancer Patients-Acute Toxicity and Treatment Quality of the Uterus-11 Multicenter Phase III Intergroup Trial of the German Radiation Oncology Group and the Gynecologic Cancer Group.
Marnitz S; Martus P; Köhler C; Stromberger C; Asse E; Mallmann P; Schmidberger H; Affonso Júnior RJ; Nunes JS; Sehouli J; Budach V
Int J Radiat Oncol Biol Phys; 2016 Feb; 94(2):243-53. PubMed ID: 26853333
[TBL] [Abstract][Full Text] [Related]
12. External Beam, Brachytherapy, or Chemotherapy? Defining Adjuvant Therapy for Early-Stage and High- and High-Intermediate-Risk Endometrial Cancer.
Jang JW; Lee LJ
J Clin Oncol; 2019 Jul; 37(21):1778-1784. PubMed ID: 31163010
[No Abstract] [Full Text] [Related]
13. Feasibility and acute toxicity of Concurrent Chemoradiotherapy (CCRT) with high-dose rate intracavitary brachytherapy (HDR-ICBT) and 40-mg/m2 weekly cisplatin for Japanese patients with cervical cancer: results of a Multi-Institutional Phase 2 Study (JGOG1066).
Toita T; Kitagawa R; Hamano T; Umayahara K; Hirashima Y; Aoki Y; Oguchi M; Mikami M; Takizawa K;
Int J Gynecol Cancer; 2012 Oct; 22(8):1420-6. PubMed ID: 22932262
[TBL] [Abstract][Full Text] [Related]
14. A phase II trial of less than 7 weeks of concomitant cisplatin-paclitaxel chemoradiation in locally advanced cervical cancer.
Martínez-Monge R; Gaztañaga M; Aramendía JM; Cambeiro M; Arbea L; Espinós J; Aristu JJ; Jurado M
Int J Gynecol Cancer; 2010 Jan; 20(1):133-40. PubMed ID: 20130514
[TBL] [Abstract][Full Text] [Related]
15. Feasibility study of toxicity outcomes using GEC-ESTRO contouring guidelines on CT based instead of MRI-based planning in locally advanced cervical cancer patients.
Koh V; Choo BA; Lee KM; Tan TH; Low JH; Ng SY; Ilancheran A; Shen L; Tang J
Brachytherapy; 2017; 16(1):126-132. PubMed ID: 27816539
[TBL] [Abstract][Full Text] [Related]
16. Can Stereotactic Body Radiotherapy Effectively Treat Hepatocellular Carcinoma?
Barry A; Knox JJ; Wei AC; Dawson LA
J Clin Oncol; 2016 Feb; 34(5):404-8. PubMed ID: 26700118
[TBL] [Abstract][Full Text] [Related]
17. [A case of stage IVb cervical carcinoma in which survival was prolonged by two different chemotherapies and CCRT].
Ishikawa M; Nakayama K; Rahman MT; Rahman M; Katagiri A; Katagiri H; Ishibashi T; Iida K; Miyazaki K
Gan To Kagaku Ryoho; 2012 Mar; 39(3):451-5. PubMed ID: 22421778
[TBL] [Abstract][Full Text] [Related]
18. Combined external and intracavitary irradiation in treatment of advanced cervical carcinomas: predictive factors for local tumor control and early recurrences.
Sorbe B; Bohr L; Karlsson L; Bermark B
Int J Oncol; 2010 Feb; 36(2):371-8. PubMed ID: 20043071
[TBL] [Abstract][Full Text] [Related]
19. Role of metastasectomy and chemotherapy in carcinoma of uterine cervix.
Ali N; Mansha MA; Abbasi AN; Qureshi BM
BMJ Case Rep; 2017 Aug; 2017():. PubMed ID: 28768676
[TBL] [Abstract][Full Text] [Related]
20. Preoperative Chemoradiotherapy in Locally Advanced Bulky Squamous Cell Carcinoma of the Uterine Cervix.
Nakao Y; Hashiguchi M; Nishiyama S; Aihara S; Iwasaka T; Yokoyama M
Int J Gynecol Cancer; 2017 Nov; 27(9):1943-1948. PubMed ID: 28786876
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]